Trial Profile

Double-Blinded, Double-Dummy, Study Comparing Salmeterol/fluticasone propionate to Placebo in Patients With COPD and Associated Poor Sleep or Daytime Somnolence.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 08 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Salmeterol/fluticasone propionate (Primary)
Indications Chronic obstructive pulmonary disease
Focus Therapeutic Use

Most Recent Events

22 Mar 2011 Results presented at the 67th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
17 May 2010 Results presented at 106th International Conference of the American Thoracic Society.
17 May 2010 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com